|
ECO Experts’ consensus on establishing renal cancer healthcare quality measures in Spain. |
|
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Janssen; Roche |
Consulting or Advisory Role - Astellas Pharma; Bayer |
Research Funding - Novartis (Inst); Roche (Inst) |
Travel, Accommodations, Expenses - Lilly; MSD Oncology; Roche |
|
|
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Janssen-Cilag; MSD Oncology; Pfizer; Pierre Fabre; Roche; Sanofi |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Clovis Oncology; Eisai; Ipsen; Janssen-Cilag; Merck Sharp & Dohme; Pfizer; Roche; Sanofi |
Research Funding - Astellas Pharma; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen-Cilag; MSD Oncology; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
Miguel Ángel Climent Durán |
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi |
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Celgene; Eisai; Janssen-Cilag; Merck; Pfizer; Roche/Genentech; Sanofi |
Travel, Accommodations, Expenses - Ipsen; Janssen; Merck; Pfizer; Roche |
|
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Merck; Merck Sharp & Dohme; Roche |
Consulting or Advisory Role - Astellas Pharma; AstraZeneca Spain; Bristol-Myers Squibb; Daiichi Sankyo; EUSA Pharma; Ipsen; Janssen Oncology; Merck KGaA; Pfizer; Roche; Sanofi; Shenzen Techdow Pharma |
Speakers' Bureau - Astellas Pharma; Daiichi Sankyo; Eisai; Ipsen; LEO Pharma; Pfizer; Roche; Rovi |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Janssen; Pfizer; Roche |
|
Aránzazu González del Alba |
No Relationships to Disclose |
|
Martín Emilio Lázaro Quintela |
No Relationships to Disclose |
|
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb; Ipsen; Roche |
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen-Cilag; Novartis; Pfizer; Roche; Sanofi |
Travel, Accommodations, Expenses - Astellas Pharma; Bristol-Myers Squibb; Janssen-Cilag; Pfizer; Roche |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Irene Santamaría Rodríguez |
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD Oncology; Novartis; Pfizer; Pierre Fabre; Roche; Sanofi/Aventis |
Research Funding - Bristol-Myers Squibb; Bristol-Myers Squibb; Pfizer |
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Janssen; Pfizer; Roche |
|
|
Honoraria - Astellas Pharma; Bristol-Myers Squibb; EUSA Pharma; Ipsen; Janssen Oncology; MSD Oncology; Roche/Genentech |
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Janssen Oncology; MSD Oncology; Novartis; Pharmacyclics; Roche/Genentech; Seagen |
Research Funding - Astellas Pharma (Inst); AstraZeneca Spain (Inst); Janssen Oncology (Inst); Roche/Genentech (Inst) |
Travel, Accommodations, Expenses - AstraZeneca Spain; Ipsen; Roche/Genentech |